ArticleNeurogenetics2025
Mutation screening of the ASPM gene in multiple Pashtun origin MCPH families revealed the recurrent nonsense mutation p.Trp1326*: A step towards the development of a genetic diagnostic test.
Article in Neurogenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microcephaly primary hereditary (MCPH) is a rare neurodevelopmental disorder characterized by a reduced head circumference and variable severity of intellectual disability, typically inherited in an autosomal recessive pattern. Mutations in over 32 genes have been associated with the etiology of MCPH to date, among which ASPM gene is the most frequently mutated, accounting for approximately 68.8% globally. In Pakistan, particularly within the Pashtun population of Khyber Pakhtunkhwa (KP), ASPM mutations are highly prevalent. In this study, we analysed clinical and genetic features of nine consanguineous MCPH families. Among these, six families revealed recurrent nonsense mutation p.Trp1326*(c.3978G > A), increasing the evidence of it being a founder mutation. In addition to this, genetic analysis of other Pashtun origin families found previously reported nonsense mutation in the same ASPM gene, which include p.Arg3244*(c.9730 C > T), p.Tyr3164*(c.9492T > G), and p.Ser1176*(c.3527 C > G). Clinical assessments of patients revealed microcephaly with mild to severe intellectual disability, impaired interpersonal skills, delayed speech, with no evidence of skeletal, muscular, and major organ abnormalities. Protein modeling and conformation analysis suggested less similarity between wild-type and mutated ASPM proteins, which ranged from 0.24% to 0.68%. Further to the current study, a total of 58 families are known to carry the ASPM p.Trp1326* mutation in the Pashtun Population. These findings emphasize the critical role of ASPM in MCPH pathogenesis, strengthening the evidence of recurrent p.Trp1326* mutation as a founder variant in the Pashtun population. The present study signifies the importance of genetic screening and counselling for effective diagnosis of MCPH in high-risk Pashtun origin Pakistani population.
Indexed as
Identifiers
41452392What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.